Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

计划入组 30 人 · 首次发布于 2021 年 6 月 3 日

R3 Delta Ceramic Acetabular System PAS U.S.

计划入组 189 人 · 首次发布于 2017 年 2 月 17 日

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3

计划入组 31 人 · 首次发布于 2023 年 2 月 8 日

APB-R3

Ph-R3

vascular agents

R3 Vascular Inc.

United States

Lemaitre Vascular

United States

BASECAMP VASCULAR

France

R3 Vascular's Magnitude Scaffold Receives FDA IDE for BTK-PAD Trial

R3 Vascular Secures $87 Million in Series B Financing and Appoints New CEO

R3 Vascular's MAGNITUDE Scaffold Receives FDA IDE Approval for BTK-PAD Trial